• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与囊腺瘤相比,低恶性潜能卵巢肿瘤培养物中染色体稳定性增加。

Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.

作者信息

Yu J, Roy D, Brockmeyer A D, Dubeau L

机构信息

Department of Pathology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089-9181, USA.

出版信息

Br J Cancer. 2007 Jun 18;96(12):1908-13. doi: 10.1038/sj.bjc.6603817. Epub 2007 May 22.

DOI:10.1038/sj.bjc.6603817
PMID:17519898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2359981/
Abstract

Cell cultures of ovarian cystadenomas transfected with SV40 large T antigen are not immortal because they invariably reach a phenomenon called crisis, which is triggered in part by telomere attrition. Recovery from crisis may be an integral component of the malignant transformation process. We reported earlier that such ovarian cystadenoma cell cultures undergo severe changes in DNA ploidy as they approach crisis and that such changes are an important determinant of crisis independent of telomere attrition. Here, we show that in sharp contrast to these benign ovarian tumours, the DNA content of ovarian tumours of low malignant potential (LMP) was remarkably stable as they approached crisis, suggesting that telomere attrition was the main determinant of this mortality checkpoint. Lack of a ploidy-based crisis was not due to loss of expression of a functional SV40 large T antigen protein. We conclude that ovarian LMP tumours are characterised by increased numerical chromosomal stability compared to cystadenomas. This might account for the fact that most LMP tumours are diploid or near diploid in vivo. This fundamental difference in chromosomal stability between ovarian cystadenomas and LMP tumours also suggests potential differences in predisposition to progression to malignancy between these two ovarian tumour subtypes.

摘要

用SV40大T抗原转染的卵巢囊腺瘤细胞培养物不会永生,因为它们总会出现一种叫做危机的现象,这种现象部分由端粒损耗引发。从危机中恢复可能是恶性转化过程的一个组成部分。我们之前报道过,此类卵巢囊腺瘤细胞培养物在接近危机时DNA倍体会发生严重变化,且这些变化是与端粒损耗无关的危机的重要决定因素。在此,我们表明,与这些良性卵巢肿瘤形成鲜明对比的是,低恶性潜能(LMP)卵巢肿瘤在接近危机时DNA含量非常稳定,这表明端粒损耗是这个死亡检查点的主要决定因素。缺乏基于倍体的危机并非由于功能性SV40大T抗原蛋白表达缺失所致。我们得出结论,与囊腺瘤相比,卵巢LMP肿瘤的特征是染色体数目稳定性增加。这可能解释了大多数LMP肿瘤在体内为二倍体或接近二倍体这一事实。卵巢囊腺瘤和LMP肿瘤在染色体稳定性上的这一根本差异也表明这两种卵巢肿瘤亚型在发展为恶性肿瘤的易感性方面可能存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/f7f6b244cf51/6603817f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/dd1f884e48c9/6603817f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/caccbcccabaa/6603817f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/33d55ce1ef77/6603817f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/f7f6b244cf51/6603817f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/dd1f884e48c9/6603817f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/caccbcccabaa/6603817f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/33d55ce1ef77/6603817f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eff/2359981/f7f6b244cf51/6603817f4.jpg

相似文献

1
Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas.与囊腺瘤相比,低恶性潜能卵巢肿瘤培养物中染色体稳定性增加。
Br J Cancer. 2007 Jun 18;96(12):1908-13. doi: 10.1038/sj.bjc.6603817. Epub 2007 May 22.
2
Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells.非整倍体和端粒损耗是SV40转化的上皮细胞危机的独立决定因素。
Cancer Res. 2003 Sep 15;63(18):5813-20.
3
Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis.DNA甲基化改变是卵巢肿瘤发生过程中的早期事件,但并非起始事件。
Br J Cancer. 1997;75(3):396-402. doi: 10.1038/bjc.1997.64.
4
Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.与卵巢癌相邻的形态学上良性囊肿与孤立性囊腺瘤之间的基因差异。
J Natl Cancer Inst. 1995 Aug 2;87(15):1146-53. doi: 10.1093/jnci/87.15.1146.
5
Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.低恶性潜能浆液性卵巢肿瘤的间期细胞遗传学分析:与浆液性囊腺瘤及浸润性浆液性癌的比较
Lab Invest. 1996 Oct;75(4):473-85.
6
Telomerase activity in benign and malignant epithelial ovarian tumors.良性和恶性上皮性卵巢肿瘤中的端粒酶活性
J Natl Cancer Inst. 1997 Mar 19;89(6):437-41. doi: 10.1093/jnci/89.6.437.
7
Differences in p16 gene methylation and expression in benign and malignant ovarian tumors.良性和恶性卵巢肿瘤中p16基因甲基化与表达的差异。
Gynecol Oncol. 1999 Jan;72(1):87-92. doi: 10.1006/gyno.1998.5235.
8
Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases.人卵巢囊腺瘤和低恶性潜能肿瘤长期体外培养体系的建立及其基质降解蛋白酶表达谱的检测
Gynecol Oncol. 1997 Dec;67(3):277-84. doi: 10.1006/gyno.1997.4880.
9
Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.1号、11号、17号染色体以及X染色体的数目异常与浆液性和黏液性上皮性卵巢肿瘤的间质浸润相关。
J Pathol. 1999 Sep;189(1):53-9. doi: 10.1002/(SICI)1096-9896(199909)189:1<53::AID-PATH393>3.0.CO;2-U.
10
Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.卵巢囊腺瘤、低恶性潜能肿瘤及浸润性癌中端粒酶活性分析。
Gynecol Oncol. 1999 Sep;74(3):338-45. doi: 10.1006/gyno.1999.5506.

引用本文的文献

1
Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.浆液性宫外 Müller 上皮癌的发病机制及治疗意义
Transl Cancer Res. 2015 Feb;4(1):3-13. doi: 10.3978/j.issn.2218-676X.2015.01.06.
2
Coming into focus: the nonovarian origins of ovarian cancer.聚焦:卵巢癌的非卵巢起源。
Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii28-viii35. doi: 10.1093/annonc/mdt308.
3
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.41 种卵巢细胞系中的 BRCA1/2 基因突变分析仅揭示了一种具有功能的 BRCA1 突变。

本文引用的文献

1
Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges.卵巢交界性肿瘤的分子发病机制:新见解与旧挑战
Clin Cancer Res. 2005 Oct 15;11(20):7273-9. doi: 10.1158/1078-0432.CCR-05-0755.
2
Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.BRAF和KRAS的突变先于卵巢浆液性交界性肿瘤的发生。
Cancer Res. 2004 Oct 1;64(19):6915-8. doi: 10.1158/0008-5472.CAN-04-2067.
3
Molecular genetic analysis of ovarian serous cystadenomas.卵巢浆液性囊腺瘤的分子遗传学分析
Mol Oncol. 2013 Jun;7(3):567-79. doi: 10.1016/j.molonc.2012.12.007. Epub 2013 Jan 31.
Lab Invest. 2004 Jun;84(6):778-84. doi: 10.1038/labinvest.3700103.
4
Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells.非整倍体和端粒损耗是SV40转化的上皮细胞危机的独立决定因素。
Cancer Res. 2003 Sep 15;63(18):5813-20.
5
Pathology of borderline (low malignant potential) ovarian tumours.交界性(低恶性潜能)卵巢肿瘤的病理学
Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):499-512. doi: 10.1053/beog.2002.0300.
6
Telomere dysfunction provokes regional amplification and deletion in cancer genomes.端粒功能障碍引发癌症基因组中的区域扩增和缺失。
Cancer Cell. 2002 Aug;2(2):149-55. doi: 10.1016/s1535-6108(02)00094-6.
7
The management of borderline epithelial tumors of the ovary.
Int J Gynecol Cancer. 2000 May;10(3):181-197. doi: 10.1046/j.1525-1438.2000.010003181.x.
8
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.端粒功能障碍会促进小鼠发生非相互易位和上皮癌。
Nature. 2000 Aug 10;406(6796):641-5. doi: 10.1038/35020592.
9
Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.不同恶性潜能的卵巢上皮性肿瘤中卫星DNA低甲基化与全基因组低甲基化的比较
Mutat Res. 1999 Jan 25;423(1-2):91-101. doi: 10.1016/s0027-5107(98)00229-2.
10
Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases.人卵巢囊腺瘤和低恶性潜能肿瘤长期体外培养体系的建立及其基质降解蛋白酶表达谱的检测
Gynecol Oncol. 1997 Dec;67(3):277-84. doi: 10.1006/gyno.1997.4880.